Nodality, Inc. Announces Data Presentation From Collaborative Program With UCB Pharma At American College of Rheumatology 2014 Annual Meeting

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Nodality, Inc., advancing the discovery, development and use of transformative therapies across broad therapeutic categories, with a focus on immunology and oncology, announced today the presentation of research findings from its collaborative partnership with UCB Pharma S.A. The data are being featured at the 2014 ACR/ARHP Annual Meeting, currently taking place in Boston, Massachusetts.

Help employers find you! Check out all the jobs and post your resume.